Veracyte (VCYT) Stock Chart & Stock Price History $27.75 +0.07 (+0.25%) As of 01:32 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Veracyte Stock Price Performance The Veracyte (VCYT) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 7.42%, with a year-to-date return of -29.94%. In the past month, the stock has increased 4.38%, reflecting recent market activity. As of the latest close, Veracyte traded at $27.68 with a market cap of $2.17 billion and volume of 2.56 million shares. Five years ago, the stock traded at $32.35, representing a 14.23% decrease over that period. At the time, it had a market cap of $1.64 billion and a volume of 803,877 shares. Receive VCYT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Veracyte and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+17.36%1 Month Performance+4.38%3 Month Performance-11.10%Year-To-Date Performance-29.94%1 Year Performance-7.42%5 Year Performance-14.23% VCYT Stock Chart for Friday, August, 8, 2025 VCYT Chart by TradingView Veracyte Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/07/2025$23.97$27.68+15.48%$27.69$25.522.56 million shs$2.17 billion08/06/2025$25.01$23.97-4.16%$24.92$23.791.39 million shs$1.88 billion08/05/2025$24.32$25.01+2.84%$25.08$24.151.55 million shs$1.96 billion08/04/2025$23.64$24.32+2.88%$24.52$23.351.21 million shs$1.90 billion08/01/2025$23.51$23.64+0.55%$23.68$22.921.74 million shs$1.85 billion07/31/2025$23.97$23.51-1.92%$24.23$23.311.66 million shs$1.84 billion07/30/2025$24.47$23.97-2.04%$24.69$23.791.89 million shs$1.88 billion07/29/2025$25.02$24.47-2.20%$25.19$24.142.30 million shs$1.92 billion07/28/2025$25.25$25.02-0.91%$25.60$24.8515.57 million shs$1.96 billion07/25/2025$23.59$25.25+7.04%$26.11$24.805.36 million shs$1.98 billion Get the Latest News and Ratings for VCYT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Veracyte and its competitors with MarketBeat's FREE daily newsletter. 07/24/2025$24.21$23.59-2.56%$24.39$23.50805,239 shs$1.85 billion07/23/2025$23.51$24.21+2.98%$24.25$23.36967,661 shs$1.90 billion07/22/2025$23.03$23.51+2.08%$23.71$23.101.12 million shs$1.84 billion07/21/2025$23.51$23.03-2.04%$23.79$22.96753,079 shs$1.80 billion07/18/2025$24.22$23.51-2.93%$24.67$22.611.61 million shs$1.84 billion07/17/2025$25.17$24.22-3.77%$25.24$24.18820,850 shs$1.90 billion07/16/2025$25.24$25.17-0.28%$25.62$24.86833,545 shs$1.97 billion07/15/2025$26.65$25.24-5.29%$27.10$25.21696,508 shs$1.98 billion07/14/2025$27.08$26.65-1.59%$27.23$26.59663,848 shs$2.09 billion07/11/2025$27.52$27.08-1.60%$27.75$26.791.07 million shs$2.12 billion07/10/2025$27.08$27.52+1.62%$27.91$26.83936,247 shs$2.16 billion07/09/2025$26.58$27.08+1.88%$27.38$26.34823,071 shs$2.08 billion07/08/2025$26.34$26.58+0.91%$26.78$26.18739,796 shs$2.08 billion07/07/2025$27.51$26.34-4.25%$27.75$26.28691,394 shs$2.06 billion Related Companies Adaptive Biotechnologies Stock Chart Beam Therapeutics Stock Chart Guardant Health Stock Chart Twist Bioscience Stock Chart 10x Genomics Stock Chart Option Care Health Stock Chart RadNet Stock Chart BrightSpring Health Services Stock Chart Sotera Health Stock Chart GeneDx Stock Chart Receive VCYT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Veracyte and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VCYT) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | SponsoredShocked one of my clients with thisTrump Schedules Controversial 'Market Reset' for September 30 Behind closed doors, the White House has orde...Altimetry | SponsoredCritical AI announcement set to ignite AI 2.0 While the market chops sideways and headlines dominate the news cycle, a small group of traders is quietly tak...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | SponsoredThe Day Silicon DiesThe Day China Left America's Supercomputers in the Dust In 200 seconds, China's quantum computer accomplish...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Veracyte, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Veracyte With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
